Cortico-cognition coupling in treatment resistant schizophrenia

被引:6
|
作者
Syeda, Warda T. [1 ]
Wannan, Cassandra M. J. [1 ]
Merritt, Antonia H. [1 ]
Raghava, Jayachandra M. [2 ,6 ]
Jayaram, Mahesh [1 ,5 ]
Velakoulis, Dennis [1 ]
Kristensen, Tina D. [2 ,3 ]
Soldatos, Rigas Filippos [1 ,9 ]
Tonissen, Shane [1 ]
Thomas, Naveen [1 ,5 ]
Ambrosen, Karen S. [2 ,3 ]
Sorensen, Mikkel E. [2 ,3 ]
Fagerlund, Birgitte [2 ,3 ]
Rostrup, Egill [2 ,3 ]
Glenthoj, Birte Y. [2 ,3 ,4 ]
Skafidas, Efstratios [1 ]
Bousman, Chad A. [1 ,7 ]
Johnston, Leigh A. [10 ]
Everall, Ian [8 ]
Ebdrup, Bjorn H. [1 ,2 ,3 ,4 ]
Pantelis, Christos [1 ,2 ,3 ,4 ,5 ,11 ]
机构
[1] Univ Melbourne & Melbourne Hlth, Melbourne Neuropsychiat Ctr, Dept Psychiat, Parkville, Vic, Australia
[2] Univ Copenhagen, Ctr Neuropsychiat Schizophrenia Res, Glostrup, Denmark
[3] Univ Copenhagen, Ctr Clin Intervent & Neuropsychiat Schizophrenia R, Mental Hlth Ctr Glostrup, Glostrup, Denmark
[4] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
[5] Sunshine Hosp, MidWest Area Mental Hlth Serv, St Albans, Vic, Australia
[6] Rigshospitalet, Dept Clin Physiol Nucl Med & PET, Funct Imaging Unit, Glostrup, Denmark
[7] Univ Calgary, Dept Med Genet Psychiat & Physiol & Pharmacol, Calgary, AB, Canada
[8] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England
[9] Natl & Kapodistrian Univ Athens Med Sch, Eginit Hosp, Dept Psychiat 1, Athens, Greece
[10] Univ Melbourne, Dept Biomed Engn, Melbourne, Vic, Australia
[11] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia
基金
英国医学研究理事会;
关键词
Partial least squares correlation; Treatment-resistant schizophrenia; Cognition; Brain structure; MRI; WORKING-MEMORY; ATTENTION; TUTORIAL; CORTEX;
D O I
10.1016/j.nicl.2022.103064
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
Background: Brain structural alterations and cognitive dysfunction are independent predictors for poor clinical outcome in schizophrenia, and the associations between these domains remains unclear. We employed a novel, multiblock partial least squares correlation (MB-PLS-C) technique and investigated multivariate cortico-cognitive patterns in patients with treatment-resistant schizophrenia (TRS) and matched healthy controls (HC). Method: Forty-one TRS patients (age 38.5 +/- 9.1, 30 males (M)), and 45 HC (age 40.2 +/- 10.6, 29 M) underwent 3T structural MRI. Volumes of 68 brain regions and seven variables from CANTAB covering memory and executive domains were included. Univariate group differences were assessed, followed by the MB-PLS-C analyses to identify group-specific multivariate patterns of cortico-cognitive coupling. Supplementary three-group analyses, which included 23 non-affected first-degree relatives (NAR), were also conducted. Results: Univariate tests demonstrated that TRS patients showed impairments in all seven cognitive tasks and volume reductions in 12 cortical regions following Bonferroni correction. The MB-PLS-C analyses revealed two significant latent variables (LVs) explaining > 90% of the sum-of-squares variance. LV1 explained 78.86% of the sum-of-squares variance, describing a shared, widespread structure-cognitive pattern relevant to both TRS patients and HCs. In contrast, LV2 (13.47% of sum-of-squares variance explained) appeared specific to TRS and comprised a differential cortico-cognitive pattern including frontal and temporal lobes as well as paired associates learning (PAL) and intra-extra dimensional set shifting (IED). Three-group analyses also identified two significant LVs, with NARs more closely resembling healthy controls than TRS patients. Conclusions: MB-PLS-C analyses identified multivariate brain structural-cognitive patterns in the latent space that may provide a TRS signature.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] DOPAMINERGIC FUNCTION IN TREATMENT RESISTANT SCHIZOPHRENIA
    Demjaha, Arsime
    Murray, Robin
    Kapur, S.
    Howes, Oliver. D.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 123 - 123
  • [42] Amisulpride monotherapy in treatment resistant schizophrenia
    Kontaxakis, V
    Havaki-Kontaxaki, BJ
    Ferentinos, PP
    Paplos, KG
    Soldatos, CR
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S515 - S515
  • [43] TREATMENT WITH GLUTAMATERGIC DRUGS IN THE RESISTANT SCHIZOPHRENIA
    de Velasco Soriano, R. Martinez
    Pando Velasco, F.
    Serrano Diaz de Otalora, M.
    Artieda Urrutia, P.
    Riaza Bermudo-Soriano, C.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [44] THE MANAGEMENT OF TREATMENT-RESISTANT SCHIZOPHRENIA
    BREIER, A
    CURRENT OPINION IN PSYCHIATRY, 1995, 8 (01) : 41 - 44
  • [45] COGNITIVE DEFICITS IN TREATMENT RESISTANT SCHIZOPHRENIA
    Millgate, Edward
    Kravariti, Eugenia
    MacCabe, James
    Hide, Olga
    SCHIZOPHRENIA BULLETIN, 2020, 46 : S56 - S57
  • [46] Effectiveness of clozapine in treatment resistant schizophrenia
    Marder, SR
    Kane, JM
    Schooler, NR
    Wirshing, WC
    Baker, R
    Ames, D
    Umbricht, D
    Ganguli, R
    Borenstein, M
    SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 187 - 187
  • [47] Clozapine for Treatment-Resistant Schizophrenia
    Manu, Peter
    Grudnikoff, Eugene
    AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (05) : E1133 - E1134
  • [48] Identifying treatment-resistant schizophrenia
    Mortimer, Ann
    BRITISH JOURNAL OF PSYCHIATRY, 2013, 202 (03) : 238 - 238
  • [49] tDCS in the treatment of hallucinations resistant of schizophrenia
    Poulet, E.
    EUROPEAN PSYCHIATRY, 2014, 29 (08) : 668 - 668
  • [50] FAMOTIDINE AS AN ADJUNCT TREATMENT OF RESISTANT SCHIZOPHRENIA
    OYEWUMI, LK
    VOLLICK, D
    MERSKEY, H
    PLUMB, C
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 1994, 19 (02): : 145 - 150